Additionally, germline mutations in BRCA1 or BRCA2 (and ATM) are significantly associated with increased risk for lethal vs. indolent PCa (6.07% vs. 1.44%, respectively) and with earlier age at death and shorter survival time [27]. Here, BRCA2 is linked to posterior cortical atrophy.